Zomedica Corp. Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay

Reuters2025-09-23

<a href="https://laohu8.com/S/ZOMDF">Zomedica Corp.</a> Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay

Zomedica Corp. has announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin & folate assay. Initially launched in early 2024 for canine use, this multiplexed assay combines two critical tests in one, allowing veterinarians to perform in-clinic testing for cobalamin and folate, which are essential in diagnosing gastrointestinal conditions. The expansion now enables testing for feline patients, addressing a significant clinical need for timely and accurate results. This advancement allows for the assessment of two important biomarkers at the point of care, delivering reference-lab quality results in under 25 minutes. The addition of feline testing capability to the TRUFORMA platform provides veterinarians with improved diagnostic efficiency and supports enhanced clinical outcomes for feline patients. Results of this new capability were announced at the time of the platform's expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076864) on September 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2569579791?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-23 18:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569579791","market":"fut","top_or_hot":-1,"title":"Zomedica Corp. Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ZOMDF\">Zomedica Corp.</a> Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin &amp; Folate Assay\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zomedica Corp. has announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin &amp; folate assay. Initially launched in early 2024 for canine use, this multiplexed assay combines two critical tests in one, allowing veterinarians to perform in-clinic testing for cobalamin and folate, which are essential in diagnosing gastrointestinal conditions. The expansion now enables testing for feline patients, addressing a significant clinical need for timely and accurate results. This advancement allows for the assessment of two important biomarkers at the point of care, delivering reference-lab quality results in under 25 minutes. The addition of feline testing capability to the TRUFORMA platform provides veterinarians with improved diagnostic efficiency and supports enhanced clinical outcomes for feline patients. Results of this new capability were announced at the time of the platform's expansion.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076864) on September 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Corp. Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Corp. Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-23 18:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ZOMDF\">Zomedica Corp.</a> Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin &amp; Folate Assay\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zomedica Corp. has announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin &amp; folate assay. Initially launched in early 2024 for canine use, this multiplexed assay combines two critical tests in one, allowing veterinarians to perform in-clinic testing for cobalamin and folate, which are essential in diagnosing gastrointestinal conditions. The expansion now enables testing for feline patients, addressing a significant clinical need for timely and accurate results. This advancement allows for the assessment of two important biomarkers at the point of care, delivering reference-lab quality results in under 25 minutes. The addition of feline testing capability to the TRUFORMA platform provides veterinarians with improved diagnostic efficiency and supports enhanced clinical outcomes for feline patients. Results of this new capability were announced at the time of the platform's expansion.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076864) on September 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZOMDF","symbol_name":"Zomedica Corp.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL9NCfKJ:1","article_id":"2569579791","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569579791","pubTimestamp":1758623417,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Zomedica Corp. has announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin & folate assay. Initially launched in early 2024 for canine use, this multiplexed assay combines two critical tests in one, allowing veterinarians to perform in-clinic testing for cobalamin and folate, which are essential in diagnosing gastrointestinal conditions. The expansion now enables testing for feline patients, addressing a significant clinical need for timely and accurate results. This advancement allows for the assessment of two important biomarkers at the point of care, delivering reference-lab quality results in under 25 minutes. The addition of feline testing capability to the TRUFORMA platform provides veterinarians with improved diagnostic efficiency and supports enhanced clinical outcomes for feline patients. Results of this new capability were announced at the time of the platform's expansion.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZOMDF":"Zomedica Corp.","BK4082":"医疗保健设备"},"translate_title":"Zomedica Corp.通过猫科动物诊断扩展TRUFORMA平台，用于钴胺素和叶酸检测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZOMDF":0.9},"content_text":"Zomedica Corp. Expands TRUFORMA Platform with Feline Diagnostics for Cobalamin & Folate Assay\n    \n\n        Zomedica Corp. has announced the expansion of its TRUFORMA diagnostic platform with the addition of feline testing capability to its cobalamin & folate assay. Initially launched in early 2024 for canine use, this multiplexed assay combines two critical tests in one, allowing veterinarians to perform in-clinic testing for cobalamin and folate, which are essential in diagnosing gastrointestinal conditions. The expansion now enables testing for feline patients, addressing a significant clinical need for timely and accurate results. This advancement allows for the assessment of two important biomarkers at the point of care, delivering reference-lab quality results in under 25 minutes. The addition of feline testing capability to the TRUFORMA platform provides veterinarians with improved diagnostic efficiency and supports enhanced clinical outcomes for feline patients. Results of this new capability were announced at the time of the platform's expansion.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076864) on September 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2569579791","isCrawlerRequest":true}